Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “multiple sclerosis”

Effectiveness of Cladribine Tablets in Participants With Highly-active Relapsing Multiple Sclerosis (CAMELOT-MS)Completed
NCT04997148N/AUpdated Dec 18, 2024
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Relapsing-Remitting Multiple Sclerosis
United Kingdom
Real World Effectiveness, Persistence, Tolerability, and Safety of Ofatumumab in Clinical PracticeCompleted
NCT06737419N/AUpdated Dec 17, 2024
Sponsor: Novartis Pharmaceuticals
Multiple Sclerosis
United States
HFS (High-Fiber Supplement) in MS (Multiple Sclerosis)Completed
NCT04574024Phase 1, Phase 2Updated Dec 17, 2024
Sponsor: Suhayl Dhib-Jalbut, MD
Multiple Sclerosis
United States
Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)Recruiting
NCT05017142N/AUpdated Dec 16, 2024
Sponsor: University of Bern
Optic Neuritis · Transverse Myelitis · Acute Disseminated Encephalomyelitis · Multiple Sclerosis
Switzerland
Imaging the Interplay Between Axonal Damage and Repair in Multiple SclerosisRecruiting
NCT05177523N/AUpdated Dec 16, 2024
Sponsor: University Hospital, Basel, Switzerland
Multiple Sclerosis (MS) · Relapsing-remitting Multiple Sclerosis (RRMS) · Secondary-progressive Multiple Sclerosis (SPMS) · Primary Progressive Multiple Sclerosis (PPMS)
Switzerland
Norwegian Study of Oral Cladribine and Rituximab in Multiple Sclerosis (NOR-MS)Completed
NCT04121403Phase 3Updated Dec 16, 2024
Sponsor: Oslo University Hospital
Relapsing Multiple Sclerosis · Multiple Sclerosis
Norway
The Effect of Yoga on Sleep Quality, Fatigue and Physical Activity Level of Multiple SclerosisCompleted
NCT06128668NAUpdated Dec 13, 2024
Sponsor: Ataturk University
Multiple Sclerosis
Turkey (Türkiye)
Gut Microbiome and DepressionTerminated
NCT05808101N/AUpdated Dec 13, 2024
Sponsor: Washington University School of Medicine
Multiple Sclerosis · Depression
United States
A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and DermatomyositisCompleted
NCT03817424Phase 1Updated Dec 13, 2024
Sponsor: Amgen
Systemic Lupus Erythematosus · Cutaneous Lupus Erythematosus · Sjogren's Syndrome · Systemic Sclerosis
United States, Poland, Spain
Cannabis as a Complementary Treatment in Multiple SclerosisRecruiting
NCT05092191Phase 2Updated Dec 13, 2024
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Multiple Sclerosis
Canada
Deep Brain Stimulation for Refractory Trigeminal Neuralgia with a Pontine LesionRecruiting
NCT05451251Phase 1Updated Dec 12, 2024
Sponsor: Université de Sherbrooke
Trigeminal Neuralgia
Canada
A Dyadic Approach for Promoting Physical Activity Among People with MS and Their Support PartnersCompleted
NCT04267185NAUpdated Dec 12, 2024
Sponsor: University of Ottawa
Multiple Sclerosis
Canada
Evaluation of the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple SclerosisTerminated
NCT04984278Phase 3Updated Dec 11, 2024
Sponsor: Jazz Pharmaceuticals
Spasticity With Multiple Sclerosis
United States, Czechia, Poland, Spain, United Kingdom
Assessing NHS ImplemeNTation of an onlinE Resilience Training Acceptance and Commitment Therapy (ACT) Programme to Prevent Job Loss in Multiple SclerosisRecruiting
NCT06728956NAUpdated Dec 11, 2024
Sponsor: The Leeds Teaching Hospitals NHS Trust
Multiple Sclerosis
United Kingdom
Tele-Exercise and Multiple SclerosisCompleted
NCT03117881NAUpdated Dec 11, 2024
Sponsor: University of Alabama at Birmingham
Multiple Sclerosis
United States
Resistance Training and Corticospinal Excitability in Multiple SclerosisRecruiting
NCT06374108NAUpdated Dec 11, 2024
Sponsor: University of Aarhus
Multiple Sclerosis
Denmark
Upper Extremity Function in Multiple Sclerosis Patients With Advanced Disability Treated With OcrevusCompleted
NCT03562975N/AUpdated Dec 10, 2024
Sponsor: University of South Florida
Multiple Sclerosis · Pathologic Processes · Demyelinating Diseases · Nervous System Diseases
United States
A "negative"dendritic Cell-based Vaccine for the Treatment of Multiple Sclerosis: a First-in-human Clinical TrialCompleted
NCT02618902Phase 1Updated Dec 9, 2024
Sponsor: University Hospital, Antwerp
Multiple Sclerosis
Belgium
Reducing Fatigue in People With Multiple Sclerosis by Treatment With TENSRecruiting
NCT05500963NAUpdated Dec 9, 2024
Sponsor: University of Colorado, Boulder
Multiple Sclerosis
United States
Implementation of Online Mindfulness-Based Stress Reduction Tailored for People with Multiple SclerosisNot Yet Recruiting
NCT06415552NAUpdated Dec 6, 2024
Sponsor: Robert Simpson
Multiple Sclerosis
Canada
Self-compassion for People with Multiple Sclerosis: an Exploratory Feasibility StudyUnknown
NCT06337903NAUpdated Dec 6, 2024
Sponsor: Robert Simpson
Multiple Sclerosis · Self-Compassion
Canada
Intervention to Reduce Perceived Cognitive Impairment in Multiple SclerosisCompleted
NCT03889327NAUpdated Dec 6, 2024
Sponsor: University of Missouri, Kansas City
Multiple Sclerosis
United States
A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS)Terminated
NCT04944784Phase 3Updated Dec 5, 2024
Sponsor: Cytokinetics
Amyotrophic Lateral Sclerosis
United States, Australia, Belgium, Canada, Denmark +11 more
Validity and Reliability of Lower Extremity Position Test in Patients with Multiple SclerosisCompleted
NCT05663541N/AUpdated Dec 5, 2024
Sponsor: Pamukkale University
Multiple Sclerosis · Sensory Impairments · Proprioceptive Disorders · Validity
Turkey (Türkiye)
Effects of Upper Extremity-Focused Neuromuscular Training in People With Multiple SclerosisNot Yet Recruiting
NCT06712342NAUpdated Dec 4, 2024
Sponsor: Istanbul Aydın University
Multiple Sclerosis

Previous page Next page